- Home
- EOSE vs ZVRA Comparison
EOSE vs ZVRA Comparison
Compare EOSE & ZVRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EOSE
- ZVRA
- Stock Information
- Founded
- EOSE 2008
- ZVRA 2006
- Country
- EOSE United States
- ZVRA United States
- Employees
- EOSE N/A
- ZVRA N/A
- Industry
- EOSE Industrial Machinery/Components
- ZVRA Biotechnology: Pharmaceutical Preparations
- Sector
- EOSE Miscellaneous
- ZVRA Health Care
- Exchange
- EOSE Nasdaq
- ZVRA Nasdaq
- Market Cap
- EOSE 542.2M
- ZVRA 473.6M
- IPO Year
- EOSE N/A
- ZVRA 2015
- Fundamental
- Price
- EOSE $2.19
- ZVRA $8.62
- Analyst Decision
- EOSE Strong Buy
- ZVRA Strong Buy
- Analyst Count
- EOSE 6
- ZVRA 7
- Target Price
- EOSE $5.42
- ZVRA $21.20
- AVG Volume (30 Days)
- EOSE 7.5M
- ZVRA 645.2K
- Earning Date
- EOSE 11-05-2024
- ZVRA 11-12-2024
- Dividend Yield
- EOSE N/A
- ZVRA N/A
- EPS Growth
- EOSE N/A
- ZVRA N/A
- EPS
- EOSE N/A
- ZVRA N/A
- Revenue
- EOSE $14,963,000.00
- ZVRA $24,489,000.00
- Revenue This Year
- EOSE $187.90
- ZVRA N/A
- Revenue Next Year
- EOSE $391.53
- ZVRA $318.48
- P/E Ratio
- EOSE N/A
- ZVRA N/A
- Revenue Growth
- EOSE 20.34
- ZVRA 47.85
- 52 Week Low
- EOSE $0.61
- ZVRA $4.20
- 52 Week High
- EOSE $3.66
- ZVRA $9.21
- Technical
- Relative Strength Index (RSI)
- EOSE 33.48
- ZVRA 53.79
- Support Level
- EOSE $2.23
- ZVRA $7.84
- Resistance Level
- EOSE $2.52
- ZVRA $9.21
- Average True Range (ATR)
- EOSE 0.26
- ZVRA 0.52
- MACD
- EOSE -0.12
- ZVRA -0.00
- Stochastic Oscillator
- EOSE 2.11
- ZVRA 56.93
About EOSE Eos Energy Enterprises Inc.
Eos Energy Enterprises Inc designs develop, manufactures, and markets zinc-based energy storage solutions for utility-scale, microgrid, and commercial & industrial (C&I) applications. The solutions are used in the utility sector, the renewable energy sector, and the industrial sector. It's flagship product Eos Znyth is a stationary battery energy storage system.
About ZVRA Zevra Therapeutics Inc.
Zevra Therapeutics Inc is a rare disease company combining science, data, and patient needs to create transformational therapies for diseases with limited or no treatment options. The company's mission is to bring life-changing therapeutics to people living with rare diseases. With unique, data-driven development and commercialization strategies, it is overcoming complex drug development challenges to make new therapies available to the rare disease community.